Taken together, our data showed that overexpression of PTOV1 is positively correlated with clinical stage; T, N, M classification; and ER expression levels, which further supported the hypothesis that the elevated PTOV1 expression is associated with breast cancer progression. This evidence concerns the gene ESR1 and breast carcinoma.